Richard Steinhart - Chief Financial Officer, Bioxcel Therapeutics, Inc

As of May 28, 2020


Richard Steinhart Net Worth

  • Net worth is estimated to be at least $347.67K
  • Owns at least 1,500 units of Bioxcel Therapeutics, Inc stock

Richard Steinhart Trading

  • Largest purchase of shares was 500 units , worth over $2.6K on December 4, 2018
  • In total has made about 5 transactions over 2 years
  • Usually trades in November, with the busiest year in 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Richard Steinhart Mailing Address

  • Mailing address is 125 Elm Street New Canaan CT 06840 CT

Bioxcel Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Vimal Mehta, Ph.D. 2020 $890,000 - $8,122,500 $556,250 $7,800 $9,576,550
Vimal Mehta, Ph.D. 2019 $459,000 - $1,269,131 $233,000 $7,800 $1,968,931
William P. Kane, Jr. 2020 $245,455 - $4,185,500 $138,699 - $4,569,654
Reina Benabou, M.D., Ph.D. 2020 $197,443 - $2,462,400 $76,341 - $2,736,184
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1720893/000110465921055605/tm212482-3_def14a.htm

Bioxcel Therapeutics, Inc Insider Trading

  • The most recent transaction was 473,250 units sold on June 29, 2021 by Vimal Mehta worth over $14.59M
  • In the last 3 years, insiders at Bioxcel Therapeutics, Inc sold an estimated value of $131.43M and bought an estimated value of $19.96M
  • The most active traders are Vimal Mehta, CEO,  Frank Yocca, Chief Scientific Officer,  and Peter Mueller, Director
  • Insider trading is most common in March, with the busiest year in 2021

BioXcel Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1